{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:40:14Z","timestamp":1792809614267,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Cangzhou Municipal Science and Technology Bureau","award":["23244102102"],"award-info":[{"award-number":["23244102102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40123-026-01505-y","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:32:49Z","timestamp":1790083969000},"page":"3727-3756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Metabolic and Skeletal Muscle-Related Profiles Associated with Annual Axial Elongation Across Optical Myopia-Control Strategies in Adolescents: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5722-5071","authenticated-orcid":false,"given":"Xue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"1","key":"1505_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s41256-025-00445-7","volume":"10","author":"W Pan","year":"2025","unstructured":"Pan W, Morgan I, Flitcroft I, et al. The need to address the myopia pandemic: summary report of the global myopia public health summit 2024. Glob Health Res Policy. 2024;10(1):45. https:\/\/doi.org\/10.1186\/s41256-025-00445-7.","journal-title":"Glob Health Res Policy"},{"issue":"1","key":"1505_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2522319","volume":"57","author":"YM Guo","year":"2025","unstructured":"Guo YM, Liu GC, Wei J, et al. Cross-sectional study of myopia prevalence and associated risk factors among children and adolescents in Shaanxi Province, China, in 2021. Ann Med. 2021;57(1):2522319. https:\/\/doi.org\/10.1080\/07853890.2025.2522319.","journal-title":"Ann Med"},{"key":"1505_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2026.124062","volume":"296","author":"XQ Zhu","year":"2026","unstructured":"Zhu XQ, Sun Y, Lin R, et al. School greenspace and myopia incidence and burden in Chinese children and adolescents: the Guangzhou children and adolescents cohort study. Environ Res. 2026;296:124062. https:\/\/doi.org\/10.1016\/j.envres.2026.124062.","journal-title":"Environ Res"},{"issue":"3","key":"1505_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/bjo-2024-325427","volume":"109","author":"J Liang","year":"2025","unstructured":"Liang J, Pu Y, Chen J, et al. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. Br J Ophthalmol. 2025;109(3):362\u201371. https:\/\/doi.org\/10.1136\/bjo-2024-325427.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"1505_CR5","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1111\/opo.70016","volume":"45","author":"WN Charman","year":"2025","unstructured":"Charman WN, Atchison DA. Myopia control and modulation transfer functions for multisegment spectacle lenses. Ophthalmic Physiol Opt. 2025;45(7):1912\u201323. https:\/\/doi.org\/10.1111\/opo.70016.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"12","key":"1505_CR6","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamapediatrics.2025.3243","volume":"179","author":"P Kotecha","year":"2025","unstructured":"Kotecha P, Huang W, Yeh YY, et al. Efficacy and safety of GLP-1 RAs in children and adolescents with obesity or type\u00a02 diabetes: a systematic review and meta-analysis. JAMA Pediatr. 2025;179(12):1308\u201317. https:\/\/doi.org\/10.1001\/jamapediatrics.2025.3243.","journal-title":"JAMA Pediatr"},{"issue":"8","key":"1505_CR7","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/s41366-025-01790-w","volume":"49","author":"LG Sedenho-Prado","year":"2025","unstructured":"Sedenho-Prado LG, Yugar LBT, Whitaker AR, et al. Metabolic outcomes and safety of GLP-1 receptor agonists in children and adolescents with obesity: a systematic review and meta-analysis. Int J Obes (Lond). 2025;49(8):1469\u201379. https:\/\/doi.org\/10.1038\/s41366-025-01790-w.","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"1505_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2025.107122","volume":"165","author":"G P\u00e9rez L\u00f3pez","year":"2025","unstructured":"P\u00e9rez L\u00f3pez G. GLP-1 receptor agonists and GIP\/GLP-1 co-agonists in the treatment of obesity in adolescents and the elderly. Agonistas del receptor GLP-1 y co-agonistas GIP\/GLP-1 en el tratamiento de la obesidad en adolescentes y ancianos. Med Clin (Barc). 2025;165(4):107122. https:\/\/doi.org\/10.1016\/j.medcli.2025.107122.","journal-title":"Med Clin (Barc)"},{"issue":"10511","key":"1505_CR9","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/S0140-6736(25)01774-X","volume":"406","author":"TS Hannon","year":"2025","unstructured":"Hannon TS, Chao LC, Barrientos-P\u00e9rez M, et al. Efficacy and safety of tirzepatide in children and adolescents with type\u00a02 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase\u00a03 trial. Lancet. 2025;406(10511):1484\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(25)01774-X.","journal-title":"Lancet"},{"issue":"8","key":"1505_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","volume":"24","author":"DJ Drucker","year":"2025","unstructured":"Drucker DJ. GLP-1-based therapies for diabetes, obesity and beyond. Nat Rev Drug Discov. 2025;24(8):631\u201350. https:\/\/doi.org\/10.1038\/s41573-025-01183-8.","journal-title":"Nat Rev Drug Discov"},{"key":"1505_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112924","volume":"229","author":"D Pantazopoulos","year":"2025","unstructured":"Pantazopoulos D, Gouveri E, Papazoglou D, Papanas N. GLP-1 receptor agonists and sarcopenia: weight loss at a cost? A brief narrative review. Diabetes Res Clin Pract. 2025;229:112924. https:\/\/doi.org\/10.1016\/j.diabres.2025.112924.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"1505_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S2213-8587(25)00226-8","volume":"13","author":"S Wharton","year":"2025","unstructured":"Wharton S, Freitas P, Hjelmes\u00e6th J, et al. Once-weekly semaglutide 7\u00b72\u00a0mg in adults with obesity (STEP UP): a randomised, controlled, phase\u00a03b trial. Lancet Diabetes Endocrinol. 2025;13(11):949\u201363. https:\/\/doi.org\/10.1016\/S2213-8587(25)00226-8.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"1505_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJMoa2502081","volume":"393","author":"WT Garvey","year":"2025","unstructured":"Garvey WT, Bl\u00fcher M, Osorto Contreras CK, et al. Coadministered cagrilintide and semaglutide in adults with overweight or obesity. N Engl J Med. 2025;393(7):635\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2502081.","journal-title":"N Engl J Med"},{"issue":"10","key":"1505_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41574-025-01160-6","volume":"21","author":"F Sanchis-Gomar","year":"2025","unstructured":"Sanchis-Gomar F, Neeland IJ, Lavie CJ. Balancing weight and muscle loss in GLP1 receptor agonist therapy. Nat Rev Endocrinol. 2025;21(10):584\u20135. https:\/\/doi.org\/10.1038\/s41574-025-01160-6.","journal-title":"Nat Rev Endocrinol"},{"key":"1505_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107927","volume":"220","author":"A Ceasovschih","year":"2025","unstructured":"Ceasovschih A, Asaftei A, Lupo MG, et al. Glucagon-like peptide-1 receptor agonists and muscle mass effects. Pharmacol Res. 2025;220:107927. https:\/\/doi.org\/10.1016\/j.phrs.2025.107927.","journal-title":"Pharmacol Res"},{"issue":"3","key":"1505_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY, et al. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363\u20138. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313739.","journal-title":"Br J Ophthalmol"},{"issue":"24","key":"1505_CR17","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","volume":"387","author":"D Weghuber","year":"2022","unstructured":"Weghuber D, Barrett T, Barrientos-P\u00e9rez M, et al. Once-weekly semaglutide in adolescents with obesity. N Engl J Med. 2022;387(24):2245\u201357. https:\/\/doi.org\/10.1056\/NEJMoa2208601.","journal-title":"N Engl J Med"},{"issue":"22","key":"1505_CR18","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","volume":"382","author":"AS Kelly","year":"2020","unstructured":"Kelly AS, Auerbach P, Barrientos-Perez M, et al. A randomized, controlled trial of liraglutide for adolescents with obesity. N Engl J Med. 2020;382(22):2117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1916038.","journal-title":"N Engl J Med"},{"issue":"6","key":"1505_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1056\/NEJMoa2407379","volume":"392","author":"CK Fox","year":"2025","unstructured":"Fox CK, Barrientos-P\u00e9rez M, Bomberg EM, et al. Liraglutide for children 6 to <12\u00a0years of age with obesity\u2014a randomized trial. N Engl J Med. 2025;392(6):555\u201365. https:\/\/doi.org\/10.1056\/NEJMoa2407379.","journal-title":"N Engl J Med"},{"key":"1505_CR20","doi-asserted-by":"publisher","first-page":"2298306","DOI":"10.1155\/2024\/2298306","volume":"2024","author":"Y Luo","year":"2024","unstructured":"Luo Y, Luo D, Li M, Tang B. Insulin resistance in pediatric obesity: from mechanisms to treatment strategies. Pediatr Diabetes. 2024. https:\/\/doi.org\/10.1155\/2024\/2298306.","journal-title":"Pediatr Diabetes"},{"issue":"12","key":"1505_CR21","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamapediatrics.2023.4038","volume":"177","author":"A Garc\u00eda-Hermoso","year":"2023","unstructured":"Garc\u00eda-Hermoso A, L\u00f3pez-Gil JF, Izquierdo M, Ram\u00edrez-V\u00e9lez R, Ezzatvar Y. Exercise and insulin resistance markers in children and adolescents with excess weight: a systematic review and network meta-analysis. JAMA Pediatr. 2023;177(12):1276\u201384. https:\/\/doi.org\/10.1001\/jamapediatrics.2023.4038.","journal-title":"JAMA Pediatr"},{"issue":"5","key":"1505_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.kint.2025.04.036","volume":"108","author":"R Raina","year":"2025","unstructured":"Raina R, Hu J, Chan EY, Hinton J, Mitsnefes MM. Metabolic syndrome-associated kidney disease in young adolescents and children. Kidney Int. 2025;108(5):791\u20138. https:\/\/doi.org\/10.1016\/j.kint.2025.04.036.","journal-title":"Kidney Int"},{"issue":"1","key":"1505_CR23","doi-asserted-by":"publisher","first-page":"2501185","DOI":"10.1080\/19490976.2025.2501185","volume":"17","author":"KM Jardon","year":"2025","unstructured":"Jardon KM, Umanets A, Gijbels A, et al. Distinct gut microbiota and metabolome features of tissue-specific insulin resistance in overweight and obesity. Gut Microbes. 2025;17(1):2501185. https:\/\/doi.org\/10.1080\/19490976.2025.2501185.","journal-title":"Gut Microbes"},{"issue":"12","key":"1505_CR24","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41366-025-01900-8","volume":"49","author":"Z Guan","year":"2025","unstructured":"Guan Z, Luo Y, Liu H, Tao S. Association of anthropometric parameter with myopia in children and adolescents: a systematic review and meta-analysis. Int J Obes (Lond). 2025;49(12):2395\u2013405. https:\/\/doi.org\/10.1038\/s41366-025-01900-8.","journal-title":"Int J Obes (Lond)"},{"issue":"8","key":"1505_CR25","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/aos.17478","volume":"103","author":"C Martinez-Perez","year":"2025","unstructured":"Martinez-Perez C, Sanchez-Tena MA, S\u00e1nchez-Gonz\u00e1lez JM, Villa-Collar C, Alvarez-Peregrina C. Influence of outdoor time on the spherical equivalent and axial length in childhood myopia: a meta-analysis. Acta Ophthalmol. 2025;103(8):864\u201378. https:\/\/doi.org\/10.1111\/aos.17478.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"1505_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.60026","volume":"8","author":"A Ha","year":"2025","unstructured":"Ha A, Lee YJ, Lee M, Shim SR, Kim YK. Digital screen time and myopia: a systematic review and dose-response meta-analysis. JAMA Netw Open. 2025;8(2):e2460026. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.60026.","journal-title":"JAMA Netw Open"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01505-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01505-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01505-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:03:47Z","timestamp":1792807427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01505-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01505-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"7 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Xue Wang, Wenying Wang, Fengmei Han, Ting Li, Weiwei Kang, Xiaorui Yang, Jian Wang, and Lidong Yang declare that they have no commercial, financial, personal, or other competing interests relevant to this work.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective observational study was reviewed and approved by the Ethics Committee of Cangzhou Central Hospital (Approval No. 2025-090-02). Because the study used existing clinical records and involved no additional participant contact or intervention, the requirement for informed consent was waived by the ethics committee. The study was conducted in accordance with the Declaration of Helsinki and applicable national regulations governing research involving human participants. The analytical dataset contained coded study identifiers only. Direct identifiers, including participant names, national identification numbers, and contact details, were removed before analysis. Access to the study data was restricted to authorized members of the research team in accordance with institutional data-protection and data-management requirements.","order":2,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}